PMA (PMA) Stock Price & Analysis
PMA (PMA) fell 2.29% to USD 1.28 as of July 25, 2026 at 18:21 UTC, according to Nexqual real-time market data.
PMA last closed at USD 1.31; the session ranged USD 1.27–1.3 on volume of 32,027 shares. Market capitalization is $16.61M, with a 52-week range of USD 0.6–3.15 (NCM). Source: Nexqual, July 25, 2026 at 18:21 UTC.
Key Statistics (as of July 25, 2026 at 18:21 UTC)
| Price | USD 1.28 |
|---|---|
| Change | ▼ 2.29% (down) |
| Previous Close | USD 1.31 |
| Open | USD 1.27 |
| Day Range | USD 1.27 – 1.3 |
| 52-Week Range | USD 0.6 – 3.15 |
| Volume | 32,027 shares |
| Market Cap | $16.61M |
| Exchange | NCM |
Technical Analysis (PMA)
Nexqual's technical model rates PMA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 18:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.32 (neutral) |
| vs SMA50 | Below (USD 1.41) |
| MACD | -0 (negative) |
Analyst Ratings (PMA)
Wall Street analysts rate PMA "None", per Nexqual as of July 25, 2026 at 18:21 UTC.
| Consensus Rating | None |
|---|
Earnings (PMA)
Source: Nexqual, July 25, 2026 at 18:21 UTC.
Financials & Fundamentals (PMA)
| Total Revenue | $24.87M |
|---|---|
| Revenue Growth (YoY) | -51.60% |
| Gross Margin | -26.03% |
| Operating Margin | -44.42% |
| Profit Margin | -41.49% |
| Current Ratio | 0.72 |
| Total Cash | $613,259 |
| Total Debt | $7.41M |
| Free Cash Flow | $-2.60M |
Source: Nexqual, July 25, 2026 at 18:21 UTC.
Financial Health Score (PMA)
Nexqual rates PMA's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 18:21 UTC.
| Growth | Critical — Revenue -52% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $613K cash vs $7M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Mixed — No data |
Ownership (PMA)
| Insider Ownership | +10.84% |
|---|---|
| Institutional Ownership | +0.78% |
| Shares Outstanding | 6.97M |
| Float | 4.56M |
| Short % of Float | +11.10% |
Source: Nexqual, July 25, 2026 at 18:21 UTC.
Leadership (PMA)
PMA is led by Zhijun Pan (age 52), CEO & Chairman of the Board, per Nexqual as of July 25, 2026 at 18:21 UTC.
| CEO & Chairman of the Board | Zhijun Pan (age 52) |
|---|---|
| Chief Financial Officer | To Wa Yiu (age 42) |
Major Backers & Investors (PMA)
Notable institutional backers of PMA include Xtx Topco Ltd, Renaissance Technologies, according to Nexqual as of July 25, 2026 at 18:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Xtx Topco Ltd | 0.36% |
| Renaissance Technologies | 0.18% |
Source: Nexqual, July 25, 2026 at 18:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRE | Cre8 Enterprise Limited | USD 2.54 | ▼ 6.27% |
| NHP | National Healthcare Properties, | USD 16 | ▲ 0.5% |
| LSE | Leishen Energy Holding Co., Ltd | USD 4.35 | ▲ 3.13% |
| RPT | Rithm Property Trust Inc. | USD 11.64 | ▼ 4.2% |
| BFS | Saul Centers, Inc. | USD 35.68 | ▼ 0.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 18:21 UTC. This page is informational and not investment advice.